Skip to main content
Equibles

JANE STREET GROUP, LLC

Position in TSHA — Taysha Gene Therapies, Inc.

CIK 1595888 NEW YORK, NY
Back to TSHA Full portfolio

Position in TSHA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,555,096
+$1,555,096 QoQ
Shares Held
228,355
Ownership
0.070%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#81
of 208 holders
Holding Since
Sep 2020
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TSHA Over Time

Shares Held

Position Value (USD)

Derivatives in TSHA

reported options exposure · as of Jun 30, 2026
CallValue
$260,142
CallShares
38,200
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,372,861,470 across 292 Biotechnology names. TSHA ranks #68 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BBIO
BridgeBio Pharma, Inc.
 2,934,193 $218,538,693
2 MDGL
Madrigal Pharmaceuticals, Inc.
 191,541 $102,847,939
3 AXSM
Axsome Therapeutics, Inc.
 403,995 $98,885,855
4 TGTX
Tg Therapeutics, Inc.
 1,752,646 $96,290,370
5 EXEL
Exelixis, Inc.
 1,402,438 $76,306,651
6 QURE
uniQure N.V.
 1,610,483 $74,178,846
7 HALO
Halozyme Therapeutics, Inc.
 694,684 $54,372,915
8 TVTX
Travere Therapeutics, Inc.
 938,699 $53,327,489

All Filings in TSHA

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,555,096 228,355
2026-06-30 $260,142 38,200
2026-03-31 $507,792 113,600
2026-03-31 $60,345 13,500
2025-12-31 $96,250 17,500
2025-12-31 $897,303 163,146
2025-12-31 $466,400 84,800
2025-09-30 $1,820,686 556,785
2025-09-30 $43,818 13,400
2025-06-30 $316,456 136,994
2025-06-30 $31,416 13,600
2024-12-31 $293,364 169,575
2024-09-30 $216,218 107,572
2024-06-30 $286,997 128,124
2024-03-31 $169,002 58,886
2023-12-31 $74,831 42,278
2020-09-30 $520,441 23,234